Biocracked
Longevity Metabolism Peptides Research Supplements Trending: supplements clinical trial longevity nad+ nootropics
Approach: conceptual metaphor. Palette: bold color field (D). A single glass eyedropper hangs just above a shallow, clear glass dish, and one golden oil droplet is caught mid-fall. Directly beneath it, a ripple spreads across the surface. The droplet stands for a small, single dose of OEA, and the widening ripple stands for the gut's natural hormone response spreading outward. The backdrop is a seamless saturated tomato-red field. The camera sits at a low three-quarter angle, with shallow depth of field and a crisp, frozen-motion macro focus on the droplet. Hard but clean studio light from the upper left gives the droplet a bright specular highlight and casts a soft, warm-red shadow. A thin electric green (#00e676) reflection runs along the rim of the dish as a subtle accent. The mood is precise, cautious and quietly curious. There is no text.
Metabolism

Peningkat GLP‑1 Alami? 300 mg OEA Nambah GLP‑1 nganti 25 % Mung 15 menit

Nova Chen · · 4 min read

Peningkat GLP‑1 Alami? Apa Sing Saktenane Ditemokake Saka Uji Klinis Anyar

Pencernaanmu sacara alami ngasilake hormon GLP‑1, hormon sing umume ditiru déning obat GLP‑1. Siji uji klinis paling anyar nunjukaké yèn dosis tunggal oleoylethanolamide (OEA) kanthi merek TRPTI™ bisa nambah produksi hormon iki mung sewates wektu 15 menit sawise dipangan. Data utama nuduhaké kenaikan 20‑25 % dibandhingake plasebo ing momen-momen penting. Bener, nanging ora podho karo efek Ozempic; rinciané penting kanggo dimangertèni.

Ringkesan Cepet

  • Jurnal: Frontiers in Endocrinology (2026), kanthi kode registrasi NCT06840080
  • Desain: urutan tetep, siji‑blind, kontrol plasebo, crossover telu periode
  • Peserta: 37 wong diwasa kanthi BMI 25‑34,9 kg/m²
  • Dosis: plasebo, 150 mg TRPTI™, utawa 300 mg TRPTI™ sawise puasa semalam
  • Pemantauan: sampel darah nganti 8 jam, nganggo panganan standar sawise 15 menit lan 4 jam pasca‑dosis
  • Parameter sing diukur: GLP‑1, GIP, DPP‑4, insulin, glukosa, lan glukagon

OEA Kuwi Apa, Lan Kenapa Penting?

Oleoylethanolamide (OEA) iku senyawa lemak sing diproduksi awak ing usus cilik. Molekul iki melu rasa nutrisi lan sinyal hormonal saka usus, dadi bagéan penting saka komunikasi antara usus lan otak babagan rasa lapar. TRPTI™ yaiku formulasi OEA sing dirancang supaya gampang diserap (bio‑available) lan mènèhi dukungan marang jalur metabolik sing gegandhengan karo napsu.

Amarga OEA minangka zat endogen, istilah "alami" lumrah dipigunakaké kanggo nerangake molekul iki. Nanging, iki ora tegesé suplemén kanthi otomatis efektif; makane riset iki dipunlaksanani kanggo mriksa apa supplementasi OEA nduwèni efek sing signifikan.

Temuan Utama: Incretin Munggah Cepet

Dosis 300 mg ngasilaké respons incretin paling kuat. Dibandhingake karo plasebo, kenaikan iki signifikan ing periode pasca‑dosis lan wektu sawise panganan standar, lan kenaikan wis katon mung 15 menit sawise ngombe. Ing titik wektu utama, konsentrasi GLP‑1 kira‑kira 20‑25 % luwih dhuwur tinimbang plasebo. GIP, incretin gedhé liya, uga nuduhaké kenaikan signifikan sing podho.

Loro temuan liya sing menarik:

  • Perubahan DPP‑4. DPP‑4 iku enzim sing ngurai incretin. Peneliti nemokake variasi konsentrasi DPP‑4 sing signifikan ing wektu‑wektu mengko, sing diduga ana hubungane karo modulasi enzim iki. Iki sinyal potensial, dudu mekanisme sing wis kabukten.
  • Asupan panganan luwih sithik. Para peserta ngonsumsi panganan luwih sithik ing loro grup TRPTI™. Abstrak nyatakake signifikansi statistik, nanging ora nyebutake ukuran efek, mula ora kènéyake potongan kalori tartamtu.

Biomarker keamanan tetep ing kisaran normal ing loro dosis, lan penulis nyatakake tolerabilitas akut sing apik.

Kenapa Iki Ora Ozempic

Frasa "peningkat GLP‑1 alami" narik kawigaten, nanging kudu dibandhingaké kanthi kritis.

Obat kaya semaglutide iku agonis reseptor GLP‑1 sing ngaktifake reseptor sacara terus‑menerus lan diuji ing uji klinis dawa, kanthi asil penurunan bobot sing lestari. TRPTI™ kerja kanthi cara béda: nambah pelepasan hormon sawisé panganan, lan uji iki mung ngukur nganti kira‑kira 8 jam sawisé dosis siji.

Kenaikan 20‑25 % hormon glikemik iku dorongan fisiologis sing relatif alon, ora podho karo aktivasi reseptor farmakologis sing kuat. Uji iki uga ora nglaporaké penurunan bobot; sing diukur mung hormon, biomarker getih, lan asupan panganan.

Cathetan Penting Sing Kudune Diketahui

  1. Efek Akut. Peserta mung nampa siji dosis. Durung dingerteni apa efek iki tetep nalika dipangan saben dina nganti minggu utawa sasi, utawa apa awak bakal adaptasi.
  2. Pendanaan Industri. Studi iki disponsori déning Gencor Pacific, lan salah siji penulis yaiku pegawai Gencor. Penulis liyané nyatakake ora ana konflik kepentingan. Iki ora mbatalaké temuan, nanging nganjuraké supaya riset iki direplikasi sacara mandiri.
  3. Siji‑Blind Lan Urutan Tetep. Peserta ora ngerti apa sing diparingi, nanging peneliti mangertèni. Kajaba iku, kabeh peserta ngalami perlakuan kanthi urutan sing padha, ora randomisasi; mulane efek urutan utawa periode ora bisa diwatesi.
  4. Sampel Cilik lan Spesifik. Cuma 37 wong diwasa sing overweight utawa obesitas kelas I sing melu. Trial ora nyakup wong diabetes, wong tuwa, utawa sing lagi nggunakake obat metabolik.
  5. Outcome Surrogate. Tingkat hormon sing luwih dhuwur lan panganan sing luwih sithik pancen menarik, nanging durung bukti penurunan bobot awet utawa perbaikan kesehatan jangka panjang.

Apa Tegese Iki Kanggo Sampeyan

  • Dosis sing diteliti: 300 mg TRPTI™ ngasilaké efek paling kuat. Dosis 150 mg uga diuji, nanging 300 mg menehi respons incretin paling gedhé, mula iki dosis sing paling didhukung data.
  • Wektu konsumsi: Ing trial, peserta ngombe nalika puasa, lan panganan standar diparingi 15 menit sadurunge, banjur panganan kapindho 4 jam mengko. Praktisé, aja ngombe adoh banget saka panganan, nanging tetep ing wektu sing wis diteliti. Durung ana bukti manawa wektu liya uga efektif.
  • Sapa sing cocok: Wong diwasa sing sehat kanthi BMI 25‑34,9 kg/m² (overweight nganti obesitas kelas I) sing kepengin nyoba pendekatan nutrisi kanggo ngatur napsu lan kesehatan metabolik. Iki populasi sing diteliti, lan bukti isih awal.
    • Wong sing saiki nggunakake obat GLP‑1, DPP‑4 inhibitor, utawa obat diabetes liyané kudu ati‑ati, amarga riset iki ora nyinaoni kombinasi.
    • Wong sing kena diabetes utawa kondisi metabolik liyané ora kalebu ing uji iki.
    • Wong sing ngandhut, nyusui, utawa nduwèni kondisi medis serius uga ora kalebu, amarga keamanan mung diuji kanthi siji dosis ing wong sehat.
    • Sapa wae sing ngarep‑arep penurunan bobot kaya obat resep kudu ngerti yèn bukti saiki ora ndhukung ekspektasi kuwi.

Ringkesan

TRPTI™ nuduhaké potensi menarik minangka tambahan kanggo ndhukung sinyal alami usus. Ing crossover trial iki, dosis siji 300 mg nambah konsentrasi GLP‑1 lan GIP kanthi kenaikan 20‑25 % mung 15 menit sawisé konsumsi, lan barengan karo asupan panganan sing luwih sithik. Keamanan katon apik ing jangka pendek. Asilé nyenengake nanging isih winates. Langkah sabanjuré yaiku uji klinis sing luwih dawa, luwih gedhé, lan ditindakake sacara mandiri kanggo ndeleng apa fluktuasi hormon iki bisa diterjemahaké dadi manfaat jangka panjang.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

Share XFacebookLinkedInRedditWhatsApp
NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: Macro science. Palette: B, warm. Extreme macro photograph of a clear glass vial of blood plasma held in a gloved hand, shot at a slight low angle so the camera looks up through the tube. The plasma is cloudy and creamy at the top, where large fat-rich particles gather, and it clears to translucent golden amber toward the bottom, showing the drop in triglyceride particles. Tiny suspended droplets catch the light as bright specks. Warm honey-colored backlight from a low window-like source glows through the liquid and casts copper highlights across the glass. The background is a soft blur of warm brown and amber, with a faint electric green reflection on the rim of the vial cap. The mood is calm, precise and cautious, with a shallow depth of field and a real clinical texture on the glass. No text or labels.
metabolism

Retatrutide Ngurangi Partikel Trigliserida Ageng nganti 84 %—Nanging Waca Dhisik

BY DR. SYNAPSE ·

Retatrutide paling misuwur amarga kemampuan ngedhunake bobot awak, nanging analisis post‑hoc saka loro uji fase 2 nemokaké efek signifikan ing getih. Partikel lipoprotein sing kebak trigliserida (TRL) gedhé mudhun nganti 84,4 % ing pasien diabetes tipe 2, lan ApoB mudhun kira‑kira 21‑24 %. Ing uji tanpa diabetes, hsCRP mudhun 54,8 % lan IL‑6 mudhun 29,6 %, nanging perubahan iki ora signifikan ing uji diabetes. Iki dudu suplemen, nanging obat resep sing durung disetujoni, lan biomarker iki mung sinyal, ora bukti penurunan risiko serangan jantung.
Approach: Macro science. Palette: B, warm. Extreme macro photograph of raw berberine: a small heap of vivid yellow-orange crystalline powder with needle-like crystal clusters, shot at a low 30-degree angle with a shallow depth of field. Beside it, a dry sliver of Berberis root bark shows its bright yellow inner wood and fibrous grain. The surface is a smooth dark walnut board. Low golden-hour side light from the left makes the crystals glint like amber glass and throws long warm copper shadows across the wood. One tiny electric green highlight reflects off a glass spatula edge in the soft background blur. The mood is quiet and investigative, with rich saturated honey and burnt-orange tones and no blue cast. Photorealistic, microscopy-like texture, no text or labels.
metabolism

Berberine vs. Metformin: Uji Pilot Nglacak Penurunan HbA1c saka 9,5% dadi 7,5%

BY HELIX WARD ·

Salah siji uji pilot cilik taun 2008 mbandhingaké berberine karo metformin ing pasien diabetes tipe 2 sing lagi diagnosa anyar. Hasilé nuduhaké penurunan HbA1c saka 9,5 % dadi 7,5 % sajrone telung wulan. Uji kapindho sing nglibataké 48 wong sing wis nampa perawatan nampilaké HbA1c mudhun saka 8,1 % dadi 7,3 % lan HOMA‑IR turun 44,7 %. Nanging loro studi iki cilik, mung kalebu wong diabetes, lan kira‑kira sapérangan peserta ngalami gangguan pencernaan. Ing ngisor iki apa data kasebut nuduhaké, apa sing ora dituduhaké, lan apa sing kudu dingerteni sadurungé mikir nggunakake berberine.
Approach: Macro science. Palette: D, bold color field. Extreme close-up microscopy-style photograph of a dense cluster of oval, rod-shaped bacterial cells, rendered as slightly wrinkled, matte, pale cream-white forms with visible surface texture. They rest on a smooth, saturated magenta-pink gel surface. Several cells in the foreground are crisp, while the rest fall into soft shallow depth of field. One cell near the center is split open and visibly hollow, to suggest a dead, heat-treated organism. Camera is a low three-quarter angle, as if through a scanning microscope. Lighting is a single hard, warm-white side light that casts short crisp shadows and creates bright rim highlights. A thin electric green (#00e676) line of reflected light traces the edge of one cell. The mood is stark, curious and quietly skeptical. There is no text and no labels.
metabolism

Bakteri Usus Sing Luwih Apik Nalika Mati: Kauntungan 29 % saka Akkermansia

BY HELIX WARD ·

Ing percobaan manungsa kaping pisan nganggokake *Akkermansia muciniphila* versi pasteurisasi (dipatèni panas), dudu sing urip, ditemokaké peningkatan sensitivitas insulin 28,62 % lan penurunan insulin puasa 34,08 % dibandhingake plasebo ing wong kegemukan lan tahan insulin. Perubahan bobot lan lemak ora ngancik tingkat signifikan sacara statistik, lan sawatara penulis nduwèni paten lan dadi co‑founder perusahaan sing ngedol bakteri iki. Artikel iki ngrembug asil studi, apa sing ora kasat mata, lan apa sing kudu dipriksa sadurunge tuku suplemen.
A softly lit editorial still life on a pale oat-colored linen surface, shot from a slightly elevated three-quarter angle in a wide landscape frame. At center-left, a small matte white ceramic dish holds a modest pile of fine off-white powder, with a tiny brushed-brass measuring spoon resting beside it. Next to the dish stands a minimalist amber glass supplement bottle with a plain cream label and no readable text. A few capsules spill casually across the linen, some translucent and some opaque ivory. On the right side of the composition, a ripe blood orange cut in half and a handful of raw almonds sit on a light ash-wood board. A sprig of fresh rosemary adds a muted green accent. A sheer glass of water catches the light and throws a soft, rippled caustic pattern across the fabric. In the background, out of focus, a woman's hand in a soft sage-green knit sleeve rests near a ceramic mug. This suggests a calm morning routine without showing a face. Behind her, a tall window casts diffused, golden-hour light from the upper left, with gentle shadows and a creamy, shallow depth of field. The palette is warm and restrained: oat, ivory, terracotta, sage, and amber, with a single pop of coral from the blood orange. A thin, abstract line of muted terracotta paint, like a brushed arc, sweeps across the upper right background. It subtly evokes a rising curve without becoming a literal chart. The mood is calm, trustworthy, and contemporary, like a premium wellness and science journal feature. The image has crisp focus on the powder and bottle, natural film-like grain, soft contrast, and generous negative space in the upper third for headline overlay. It looks like a high-end editorial photograph with no text, logos, or futuristic elements.
metabolism

Panemuan Kapisan Manungsa NMN: 250 mg Saben Dina Nambah Sensitivitas Insulin Otot Kira‑kira 25 % ing Wanita Prediabetes

BY DR. SYNAPSE ·

NMN wis suwe dadi idola ing pasar anti‑penuaan, nanging bukti saka manungsa durung kuwat nganti ana uji coba Washington University ing 2021 sing diterbitake ing *Science*. Ing wanita menopause sing kena prediabetes lan kegemukan utawa obesitas, 250 mg NMN saben dina sajrone 10 minggu nambah sensitivitas insulin otot kira‑kira 25 %. Sinyal insulin ing otot lan gén sing kagandheng karo remodeling otot uga membaik, déné kelompok plasebo ora ana owah‑owahan. Nanging keuntungan iki winates, lan studi ora nuduhaké NMN mudhunaké glukosa darah utawa mbalèkaké prediabetes. Ing ngisor iki gambaran apa sing ditemokaké, sapa sing bisa entuk manfaat, lan apa sing ora diganti.

This page is available in

English العربيةবাংলাČeštinaDeutschEspañolفارسیFrançaisHausaहिन्दीHrvatskiBahasa IndonesiaItaliano日本語Basa Jawa한국어NederlandsਪੰਜਾਬੀPolskiPortuguêsRomânăРусскийSrpskiTürkçeУкраїнськаTiếng Việt中文